About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2014 (2014), Article ID 290878, 9 pages
http://dx.doi.org/10.1155/2014/290878
Research Article

CD49b, a Major Marker of Regulatory T-Cells Type 1, Predicts the Response to Antiviral Therapy of Recurrent Hepatitis C after Liver Transplantation

1Centre de Transplantation Hépatique, Pôle Digestif, APHP, Hôpital Saint Antoine, 184 Rue de Faubourg Saint Antoine, 75012 Paris, France
2UPMC Université Paris 6, Inserm, UMR_S938, Centre de Recherche Saint Antoine, 75012 Paris, France
3UMR 8161, Institut de Biologie de Lille, 1 Rue du Professeur Calmette, 59028 Lille, France
4Unité de Biostatistique, Hôpital Cochin, 27 Rue du Faubourg Saint-Jacques, 75014 Paris, France

Received 30 April 2013; Revised 8 October 2013; Accepted 14 October 2013; Published 19 January 2014

Academic Editor: Kenichi Harada

Copyright © 2014 Stenard Fabien et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Stenard Fabien, Morales Olivier, Ghazal Khaldoun, et al., “CD49b, a Major Marker of Regulatory T-Cells Type 1, Predicts the Response to Antiviral Therapy of Recurrent Hepatitis C after Liver Transplantation,” BioMed Research International, vol. 2014, Article ID 290878, 9 pages, 2014. doi:10.1155/2014/290878